Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

PRAXPraxis Precision Medicines, Inc.

Nasdaq · CIK 0001689548
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts251

Identity from submissions API

NamePraxis Precision Medicines, Inc.
CIK0001689548
TickersPRAX
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-300-8460
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
99 HIGH STREET, 30TH FLOOR
BOSTON
MA
02110
MA
Mailing address
99 HIGH STREET, 30TH FLOOR
BOSTON
MA
02110
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

519 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 4 FORM 4 0001689548-26-000095 4943
2026-11-18 4 FORM 4 0001689548-26-000094 4926
2026-11-18 4 FORM 4 0001689548-26-000093 4948
2026-11-18 4 FORM 4 0001689548-26-000092 4954
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000940594-26-000076 005-92098 261557668 34 10667
2026-11-12 8-K 8-K 7.01,8.01,9.01 0001689548-26-000091 001-39620 261547982 34 20070129 1 1
2026-11-09 10-Q 10-Q 0001689548-26-000089 001-39620 261536502 34 5991370 1 1
2026-11-09 8-K 8-K 2.02,9.01 0001689548-26-000086 001-39620 261533765 34 260284 1 1
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002828 005-92098 261526282 34 11692
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000940594-26-000055 005-92098 261279749 34 10596
2026-08-06 10-Q 10-Q 0001689548-26-000083 001-39620 261246248 34 5861372 1 1
2026-08-06 8-K 8-K 2.02,7.01,9.01 0001689548-26-000082 001-39620 261246240 34 5842307 1 1
2026-07-08 4 FORM 4 0001707657-26-000008 6358
2026-07-07 8-K 8-K 8.01 0001689548-26-000072 001-39620 261160027 34 148275 1 1
2026-07-02 8-K FORM 8-K 4.01,9.01 0001104659-26-080356 001-39620 261151841 34 200353 1 1
2026-06-29 8-K 8-K 8.01 0001689548-26-000069 001-39620 261136369 34 148544 1 1
2026-06-26 4 FORM 4 0001930479-26-000003 32418
2026-06-24 144 xsl144X01/primary_doc.xml 0001959173-26-004864 001-39620 261116109 33 4383
2026-06-22 8-K 8-K 8.01 0001689548-26-000066 001-39620 261107667 34 146173 1 1
2026-06-12 4 FORM 4 0001689548-26-000064 7578
2026-06-12 4 FORM 4 0001689548-26-000063 7597
2026-06-12 4 FORM 4 0001689548-26-000062 7533
2026-06-12 4 FORM 4 0001689548-26-000061 7579
2026-06-12 4 FORM 4 0001689548-26-000060 7597
2026-06-12 4 FORM 4 0001689548-26-000059 7563
2026-06-12 4 FORM 4 0001689548-26-000058 7749
2026-06-12 4 FORM 4 0001689548-26-000057 7520
2026-06-12 8-K 8-K 5.07 0001689548-26-000056 001-39620 261087546 34 159719 1 1
2026-06-01 8-K 8-K 8.01 0001689548-26-000053 001-39620 261051315 34 148373 1 1
2026-05-19 4 FORM 4 0001827639-26-000007 4956
2026-05-19 4 FORM 4 0001827760-26-000007 4927
2026-05-19 4 FORM 4 0001689548-26-000050 4951
2026-05-19 4 FORM 4 0001781480-26-000008 4908
2026-05-19 4 FORM 4 0001707657-26-000005 5619
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062582 005-92098 26987890 34 19965
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-003465 005-92098 26987760 34 17115
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000940594-26-000038 005-92098 26985196 34 10595
2026-05-07 8-K 8-K 2.02,7.01,9.01 0001689548-26-000049 001-39620 26973530 34 5778281 1 1
2026-05-07 10-Q 10-Q 0001689548-26-000047 001-39620 26951174 34 5354687 1 1
2026-05-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-001292 005-92098 26946942 34 11311
2026-04-30 DEFA14A DEFA14A 0001689548-26-000040 001-39620 26925723 34 1343761
2026-04-30 DEF 14A DEF 14A 0001689548-26-000039 001-39620 26925630 34 5568909 1 1
2026-04-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000894 005-92098 26921842 34 7380
2026-04-14 8-K 8-K 8.01 0001689548-26-000033 001-39620 26861602 34 145472 1 1
2026-04-06 8-K 8-K 8.01 0001689548-26-000031 001-39620 26841509 34 151406 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002052 005-92098 26802906 34 7145
2026-02-19 S-8 FORM S-8 0001104659-26-017306 333-293567 26651675 33 256770 1 1
2026-02-19 10-K 10-K 0001689548-26-000029 001-39620 26651561 34 11197574 1 1
2026-02-19 8-K 8-K 2.02,9.01 0001689548-26-000028 001-39620 26651559 34 273315 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001140 005-92098 26642261 34 17854
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-054527 005-92098 26640557 34 10514
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000940594-26-000016 005-92098 26638630 34 16407
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000917 005-92098 26623725 34 12373
2026-02-10 4 FORM 4 0001689548-26-000018 9323
2026-02-10 4 FORM 4 0001689548-26-000017 9493
2026-02-10 8-K/A 8-K/A 5.02,9.01 0001689548-26-000016 001-39620 26616878 34 195967 1 1
2026-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000505 005-92098 26602015 34 11356
2026-01-13 4 FORM 4 0001827639-26-000005 4800
2026-01-13 4 FORM 4 0001781480-26-000006 4753
2026-01-13 4 FORM 4 0001827760-26-000005 4772
2026-01-13 4 FORM 4 0001863297-26-000005 4795
2026-01-12 4 FORM 4 0001689548-26-000014 9064
2026-01-12 4 FORM 4 0001689548-26-000013 9014
2026-01-12 4 FORM 4 0001689548-26-000012 9034
2026-01-12 4 FORM 4 0001689548-26-000011 9051
2026-01-12 4 FORM 4 0001689548-26-000010 9724
2026-01-12 3 FORM 3 0001689548-26-000009 368895
2026-01-12 3 FORM 3 0001689548-26-000008 369096
2026-01-09 4 FORM 4 0001827639-26-000002 4799
2026-01-09 4 FORM 4 0001827760-26-000002 4771
2026-01-09 4 FORM 4 0001863297-26-000002 4795
2026-01-09 4 FORM 4 0001707657-26-000002 5463
2026-01-09 3 FORM 3 0001689548-26-000007 376513
2026-01-08 8-K 8-K 5.02 0001689548-26-000005 001-39620 26520366 34 155630 1 1
2026-01-07 8-K FORM 8-K 8.01,9.01 0001104659-26-001825 001-39620 26516621 34 559279 1 1
2026-01-07 424B5 424B5 0001104659-26-001823 333-284016 26516608 33 704166 1 1
2026-01-06 8-K 8-K 2.02 0001689548-26-000002 001-39620 26511905 34 149828 1 1
2026-01-06 424B5 424B5 0001104659-26-001307 333-284016 26511623 33 620027
2025-12-31 4 FORM 4 0001707657-25-000004 5356
2025-12-29 8-K 8-K 8.01 0001689548-25-000118 001-39620 251603174 34 145525 1 1
2025-12-11 8-K 8-K 8.01 0001689548-25-000116 001-39620 251565295 34 151073 1 1
2025-12-08 8-K 8-K 8.01 0001689548-25-000114 001-39620 251556325 34 157659 1 1
2025-11-21 4 OWNERSHIP DOCUMENT 0001104659-25-115100 4908
2025-11-21 4 OWNERSHIP DOCUMENT 0001104659-25-115099 29496
2025-11-21 4 OWNERSHIP DOCUMENT 0001104659-25-115098 33769
2025-11-20 144 xsl144X01/primary_doc.xml 0001959173-25-007151 001-39620 251501769 33 5882
2025-11-20 144 xsl144X01/primary_doc.xml 0001959173-25-007150 001-39620 251501746 33 6958
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004979 005-92098 251485467 34 18164
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004950 005-92098 251483854 34 10433
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000080255-25-000837 005-92098 251483455 34 7674
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000284 005-92098 251483155 34 10667
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000579 005-92098 251461732 34 12245
2025-11-05 10-Q 10-Q 0001689548-25-000111 001-39620 251451882 34 5757861 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001689548-25-000110 001-39620 251451877 34 269271 1 1
2025-11-03 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004715 005-92098 251444177 34 12553
2025-10-21 8-K 8-K 7.01,8.01,9.01 0001689548-25-000103 001-39620 251405392 34 9185121 1 1
2025-10-20 8-K FORM 8-K 8.01,9.01 0001104659-25-100488 001-39620 251401812 34 777274 1 1
2025-10-20 424B5 424B5 0001104659-25-100487 333-284016 251401808 33 832383 1 1
2025-10-17 4 xslF345X05/ownership.xml 0000902664-25-004455 28907
2025-10-16 424B5 424B5 0001104659-25-100136 333-284016 251398317 33 666769
2025-10-16 8-K 8-K 7.01,8.01,9.01 0001689548-25-000100 001-39620 251396400 34 4292048 1 1
2025-09-25 4 FORM 4 0001689548-25-000096 13547
2025-09-05 8-K FORM 8-K 8.01,9.01 0001104659-25-087865 001-39620 251297281 34 510648 1 1
2025-09-05 424B5 424B5 0001104659-25-087861 333-284016 251297257 33 581442 1 1
2025-09-02 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003938 005-92098 251285463 34 12365
2025-08-19 3 xslF345X02/ownership.xml 0000902664-25-003755 8047
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003695 005-92098 251220711 34 18158
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-003434 005-92098 251217851 34 10867
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000212 005-92098 251215583 34 10667
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003499 005-92098 251204324 34 12361
2025-08-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-072152 005-92098 251185943 34 19623
2025-08-04 8-K 8-K 2.02,7.01,8.01,9.01 0001689548-25-000094 001-39620 251178277 34 3751314 1 1
2025-08-04 10-Q 10-Q 0001689548-25-000092 001-39620 251178212 34 5602676 1 1
2025-07-22 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-097436 005-92098 251138934 34 19881
2025-07-17 8-K 8-K 7.01,8.01 0001689548-25-000086 001-39620 251128854 34 149814 1 1
2025-06-27 4 FORM 4 0001689548-25-000081 5284
2025-06-27 4 FORM 4 0001689548-25-000080 5258
2025-06-27 4 FORM 4 0001689548-25-000079 5244
2025-06-27 4 FORM 4 0001689548-25-000078 5301
2025-06-27 4 FORM 4 0001689548-25-000077 5316
2025-06-27 4 FORM 4 0001689548-25-000076 5318
2025-06-27 8-K 8-K 5.07 0001689548-25-000075 001-39620 251087151 34 159813 1 1
2025-06-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000185 005-92098 251029588 34 10667
2025-05-19 4 FORM 4 0001689548-25-000066 5480
2025-05-19 4 FORM 4 0001689548-25-000065 4812
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-013262 005-92098 25956174 34 24874
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002432 005-92098 25954340 34 20485
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072732 005-92098 25954076 34 10524
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002195 005-92098 25951707 34 10747
2025-05-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000119 005-92098 25943751 34 9388
2025-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001422848-25-000078 005-92098 25938171 34 7429
2025-05-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002244 005-92098 25932864 34 15671
2025-05-02 8-K 8-K 7.01,8.01,9.01 0001689548-25-000062 001-39620 25909889 34 6789901 1 1
2025-05-02 10-Q 10-Q 0001689548-25-000058 001-39620 25905612 34 5140403 1 1
2025-05-02 8-K 8-K 2.02,9.01 0001689548-25-000056 001-39620 25905606 34 259968 1 1
2025-04-30 DEFA14A DEFA14A 0001689548-25-000051 001-39620 25895784 34 1321826
2025-04-30 DEF 14A DEF 14A 0001689548-25-000050 001-39620 25895739 34 3964807 1 1
2025-03-19 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-025135 005-92098 25753551 34 30013
2025-02-28 S-8 FORM S-8 0001104659-25-018742 333-285398 25682971 33 228586 1 1
2025-02-28 S-8 FORM S-8 0001104659-25-018741 333-285397 25682960 33 210172 1 1
2025-02-28 10-K 10-K 0001689548-25-000040 001-39620 25682809 34 9267158 1 1
2025-02-28 8-K 8-K 2.02,9.01 0001689548-25-000037 001-39620 25682803 34 268023 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004233 005-92098 25631555 34 24902
2025-02-14 4 FORM 4 0001689548-25-000027 4777
2025-02-14 4 FORM 4 0001689548-25-000026 4805
2025-02-14 4 FORM 4 0001689548-25-000025 5469
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021207 005-92098 25628897 34 10689
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-001036 005-92098 25628623 34 18392
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001099 005-92098 25627295 34 10777
2025-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000895421-25-000236 005-92098 25591266 34 11846
2025-01-29 8-K 8-K 2.02,9.01 0001689548-25-000021 001-39620 25570360 34 226740 1 1
2025-01-14 4 FORM 4 0001689548-25-000016 9078
2025-01-14 4 FORM 4 0001689548-25-000015 8138
2025-01-14 4 FORM 4 0001689548-25-000014 9066
2025-01-14 4 FORM 4 0001689548-25-000013 9050
2025-01-08 4 FORM 4 0001689548-25-000008 5469
2025-01-08 4 FORM 4 0001689548-25-000007 4804
2025-01-08 4 FORM 4 0001689548-25-000006 4777
2025-01-08 4 FORM 4 0001689548-25-000005 4801
2024-12-23 S-3ASR S-3ASR 0001104659-24-131298 333-284016 241573758 33 1213302
2024-11-19 4 OWNERSHIP DOCUMENT 0001104659-24-120748 4966
2024-11-19 4 OWNERSHIP DOCUMENT 0001104659-24-120746 4962
2024-11-15 4 OWNERSHIP DOCUMENT 0001104659-24-119844 9177
2024-11-15 4 OWNERSHIP DOCUMENT 0001104659-24-119843 9205
2024-11-14 SC 13G/A p24-3173sc13ga.htm 0000902664-24-006656 005-92098 241465313 34 104285
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119332 005-92098 241464786 34 157363
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119292 005-92098 241464726 34 88787
2024-11-14 SC 13G/A cormorant-prax093024a2.htm 0001172661-24-005057 005-92098 241460786 34 87011
2024-11-14 144 xsl144X01/primary_doc.xml 0001959173-24-007844 001-39620 241460466 33 4823
2024-11-14 144 xsl144X01/primary_doc.xml 0001959173-24-007842 001-39620 241460057 33 5348
2024-11-14 SC 13G prax13gsep24.txt 0000080255-24-001466 005-92098 34 6452
2024-11-14 SC 13G/A sadaveritionpraxis_sc13ga1.htm 0000905148-24-003080 005-92098 241457734 34 93912
2024-11-12 SC 13G/A UnitedStates_13G__PraxisPrec.txt 0000932471-24-001134 005-92098 241449315 34 6537
2024-11-12 SC 13G SEC SCHEDULE 13G 0001422848-24-000366 005-92098 241446543 34 18155
2024-11-12 SC 13G/A PRAXIS PRECISION MEDICINES, INC. 0000902664-24-006413 005-92098 241444245 34 72079
2024-11-08 SC 13G us74006w2070_110824.txt 0002012383-24-003391 005-92098 241439521 34 13818
2024-11-06 10-Q 10-Q 0001689548-24-000101 001-39620 241429280 34 5237506 1 1
2024-11-06 8-K 8-K 2.02,7.01,9.01 0001689548-24-000098 001-39620 241429278 34 7342108 1 1
2024-11-04 SC 13G/A UnitedStates_13G__PraxisPrec.txt 0000932471-24-000630 005-92098 241422291 34 5586
2024-10-22 SC 13G us74006w2070_102224.txt 0002012383-24-001244 005-92098 241386089 34 13806
2024-10-15 8-K FORM 8-K 5.02,9.01 0001104659-24-108345 001-39620 241369341 34 296449 1 1
2024-09-23 SC 13G SC 13G 0001193125-24-223820 005-92098 241317180 34 63756
2024-09-03 8-K FORM 8-K 7.01,8.01,9.01 0001104659-24-096035 001-39620 241272087 34 9783806 1 1
2024-08-13 10-Q 10-Q 0001689548-24-000088 001-39620 241198773 34 5232078 1 1
2024-08-13 8-K 8-K 2.02,7.01,9.01 0001689548-24-000086 001-39620 241198768 34 6162955 1 1
2024-07-31 4 OWNERSHIP DOCUMENT 0001104659-24-084506 5584
2024-07-31 4 OWNERSHIP DOCUMENT 0001104659-24-084505 7592
2024-07-31 4 OWNERSHIP DOCUMENT 0001104659-24-084504 7621
2024-07-31 4 OWNERSHIP DOCUMENT 0001104659-24-084502 7616
2024-07-01 SC 13G SC 13G 0001104659-24-077011 005-92098 241092746 34 88031
2024-06-10 S-8 POS FORM S-8 POS 0001104659-24-070062 333-276786 241033524 33 115016
2024-06-06 4 FORM 4 0001689548-24-000079 5304
2024-06-06 4 FORM 4 0001689548-24-000078 5287
2024-06-06 4 FORM 4 0001689548-24-000077 5319
2024-06-06 4 FORM 4 0001689548-24-000076 5321
2024-06-06 4 FORM 4 0001689548-24-000075 5261
2024-06-06 4 FORM 4 0001689548-24-000074 5289
2024-06-06 8-K 8-K 5.02,5.07,9.01 0001689548-24-000073 001-39620 241026370 34 324763 1 1
2024-05-20 4 FORM 4 0001689548-24-000064 4818
2024-05-20 4 FORM 4 0001689548-24-000063 5488
2024-05-13 10-Q 10-Q 0001689548-24-000060 001-39620 24937002 34 4765004 1 1
2024-05-13 8-K 8-K 2.02,8.01,9.01 0001689548-24-000058 001-39620 24936998 34 257568 1 1
2024-04-26 DEFA14A DEFA14A 0001689548-24-000049 001-39620 24878773 34 1349239
2024-04-26 DEF 14A DEF 14A 0001689548-24-000048 001-39620 24878760 34 2502846
2024-03-29 8-K FORM 8-K 8.01,9.01 0001104659-24-041158 001-39620 24804433 34 665472 1 1
2024-03-29 424B5 424B5 0001104659-24-041157 333-277656 24804406 33 621966
2024-03-27 424B5 424B5 0001104659-24-039744 333-277656 24791536 33 620159
2024-03-26 8-K 8-K 8.01 0001689548-24-000041 001-39620 24780870 34 164987 1 1
2024-03-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-03-12 16:00:00 9999999995-24-000649 333-277656 24744490 33 1742
2024-03-08 CORRESP filename1.htm 0001104659-24-032476 8538
2024-03-08 UPLOAD filename1.pdf 0000000000-24-002587 333-277656 40300
2024-03-05 S-3 S-3 0001104659-24-030794 333-277656 24718460 33 1254083
2024-03-05 S-8 FORM S-8 0001104659-24-030762 333-277652 24718290 33 78824
2024-03-05 8-K 8-K 2.02,7.01,8.01,9.01 0001689548-24-000035 001-39620 24718260 34 5690390 1 1
2024-03-05 10-K 10-K 0001689548-24-000034 001-39620 24718257 34 8670506 1 1
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024222 005-92098 24641687 34 150662
2024-02-14 4 FORM 4 0001689548-24-000027 4800
2024-02-14 SC 13G/A p24-0502sc13ga.htm 0000902664-24-001691 005-92098 24638232 34 97463
2024-02-14 4 FORM 4 0001689548-24-000026 4772
2024-02-14 4 FORM 4 0001689548-24-000025 4779
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023605 005-92098 24637908 34 113094
2024-02-14 SC 13G/A AMENDMENT NO. 1 0000929638-24-000650 005-92098 24636559 34 97326
2024-02-14 SC 13G/A SC 13G/A 0001580642-24-000986 005-92098 24634934 34 55973
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023117 005-92098 24633406 34 57111
2024-02-14 SC 13G SC 13G 0001140361-24-007733 005-92098 24632723 34 89386
2024-02-13 SC 13G/A d10978747_13g-a.htm 0000919574-24-001171 005-92098 24631026 34 192737
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-033803 005-92098 24626582 34 77456
2024-02-09 SC 13G/A SC 13G/A 0001193125-24-030342 005-92098 24616235 34 143249
2024-02-07 SC 13G/A PRAXIS PRECISION MEDICINES, INC. 0000902664-24-001176 005-92098 24602200 34 96072
2024-02-06 SC 13G/A d10943124_13g-a.htm 0000919574-24-000689 005-92098 24601154 34 148260
2024-02-05 SC 13G/A SC 13G/A 0001178913-24-000363 005-92098 24594214 34 95583
2024-01-31 S-8 FORM S-8 0001104659-24-008806 333-276786 24583187 33 273345
2024-01-17 4 FORM 4 0001689548-24-000021 5663
2024-01-17 4 FORM 4 0001689548-24-000020 5644
2024-01-17 4 FORM 4 0001689548-24-000019 5636
2024-01-17 4 FORM 4 0001689548-24-000018 5664
2024-01-12 8-K FORM 8-K 8.01,9.01 0001104659-24-003764 001-39620 24532926 34 668952 1 1
2024-01-12 424B5 424B5 0001104659-24-003763 333-260726 24532903 33 615401
2024-01-11 8-K 8-K 1.02 0001689548-24-000013 001-39620 24527905 34 159119 1 1
2024-01-10 424B5 424B5 0001104659-24-003034 333-260726 24527373 33 615682
2024-01-10 8-K 8-K 2.02,3.02,8.01 0001689548-24-000011 001-39620 24526708 34 168396 1 1
2024-01-09 4 FORM 4 0001689548-24-000008 4952
2024-01-09 4 FORM 4 0001689548-24-000007 4924
2024-01-09 4 FORM 4 0001689548-24-000006 4931
2024-01-09 4 FORM 4 0001689548-24-000005 4952
2023-12-07 8-K FORM 8-K 1.01,9.01 0001104659-23-124348 001-39620 231473370 34 530710 1 1
2023-12-07 424B5 424B5 0001104659-23-124344 333-260726 231473327 33 450168
2023-12-01 8-K 8-K 5.03,8.01,9.01 0001689548-23-000162 001-39620 231460026 34 264544 1 1
2023-11-22 8-K FORM 8-K 8.01 0001104659-23-120776 001-39620 231433885 34 203575 1 1
2023-11-07 10-Q 10-Q 0001689548-23-000159 001-39620 231381600 34 4384223 1 1
2023-11-07 8-K 8-K 2.02,9.01 0001689548-23-000157 001-39620 231381594 34 262213 1 1
2023-11-06 8-K 8-K 5.07 0001689548-23-000150 001-39620 231380291 34 166391 1 1
2023-10-16 DEF 14A DEF 14A 0001689548-23-000145 001-39620 231326195 34 730477
2023-10-10 4 FORM 4 0001689548-23-000141 4404
2023-10-04 PRE 14A PRE 14A 0001689548-23-000139 001-39620 231306587 34 730776
2023-10-02 8-K 8-K 8.01 0001689548-23-000133 001-39620 231298813 34 173938 1 1
2023-08-09 10-Q 10-Q 0001689548-23-000128 001-39620 231153509 34 4318005 1 1
2023-08-09 8-K 8-K 2.02,7.01,8.01,9.01 0001689548-23-000126 001-39620 231153488 34 7040528 1 1
2023-07-03 SC 13G/A schedule13g.htm 0000929638-23-001891 005-92098 231065317 34 110365
2023-06-30 SC 13G PRAXIS PRECISION MEDICINES, INC. 0000902664-23-003803 005-92098 231062461 34 99896
2023-06-30 SC 13G SC 13G 0001104659-23-077120 005-92098 231061885 34 161553
2023-06-28 SC 13D/A AMENDMENT NO. 1 TO THE SCHEDULE 13D 0000921895-23-001600 005-92098 231052872 34 177335
2023-06-27 4 FORM 4 0001689548-23-000115 5719
2023-06-27 SC 13G/A SC 13G/A 0001178913-23-002298 005-92098 231044633 34 93926
2023-06-26 SC 13G PRAXIS PRECISION MEDICINES, INC. 0000902664-23-003735 005-92098 231042753 34 117069
2023-06-22 SC 13G SC 13G 0001178913-23-002270 005-92098 231032058 34 99989
2023-06-20 8-K FORM 8-K 8.01,9.01 0001104659-23-072550 001-39620 231023351 34 681606 1 1
2023-06-20 424B5 424B5 0001104659-23-072451 333-260726 231023207 33 585323
2023-06-16 8-K 8-K 1.02 0001689548-23-000113 001-39620 231019340 34 178304 1 1
2023-06-16 FWP FWP 0001104659-23-071781 333-260726 231019221 34 46894
2023-06-15 424B5 424B5 0001104659-23-071683 333-260726 231018558 33 563014
2023-06-14 4 FORM 4 0001689548-23-000111 5311
2023-06-14 4 FORM 4 0001689548-23-000110 5326
2023-06-14 4 FORM 4 0001689548-23-000109 5268
2023-06-14 4 FORM 4 0001689548-23-000108 5328
2023-06-14 4 FORM 4 0001689548-23-000107 5296
2023-06-14 4 FORM 4 0001689548-23-000106 5294
2023-06-14 8-K 8-K 5.07 0001689548-23-000105 001-39620 231012990 34 191757 1 1
2023-06-09 8-K 8-K 8.01 0001689548-23-000095 001-39620 231003852 34 181828 1 1
2023-06-08 SC 13G/A us74006w1080_060623.txt 0001306550-23-009218 005-92098 231001416 34 12371
2023-06-05 DEFA14A DEFA14A 0001104659-23-068018 001-39620 23992390 34 384090
2023-05-18 4 FORM 4 0001689548-23-000092 4779
2023-05-18 4 FORM 4 0001689548-23-000091 4752
2023-05-18 4 FORM 4 0001689548-23-000090 4758
2023-05-11 10-Q 10-Q 0001689548-23-000086 001-39620 23908866 34 4046874 1 1
2023-05-11 8-K 8-K 2.02,7.01,8.01,9.01 0001689548-23-000084 001-39620 23908844 34 6677128 1 1
2023-04-28 DEFA14A DEFA14A 0001689548-23-000074 001-39620 23866329 34 1225893
2023-04-28 DEF 14A DEF 14A 0001689548-23-000072 001-39620 23866150 34 2431674
2023-04-27 SC 13G SC 13G 0001104659-23-051366 005-92098 23857232 34 66787
2023-04-17 8-K 8-K 7.01,9.01 0001689548-23-000062 001-39620 23822948 34 6500152 1 1
2023-04-06 4/A OWNERSHIP DOCUMENT 0001104659-23-042818 5322
2023-03-27 4 OWNERSHIP DOCUMENT 0001104659-23-037023 7207
2023-03-27 4 OWNERSHIP DOCUMENT 0001104659-23-037022 5050
2023-03-27 4 OWNERSHIP DOCUMENT 0001104659-23-037021 5099
2023-03-21 8-K FORM 8-K 5.02,8.01,9.01 0001104659-23-035170 001-39620 23750605 34 286410 1 1
2023-03-20 SC 13D SCHEDULE 13D 0001193805-23-000359 005-92098 23745033 34 208915
2023-03-10 8-K 8-K 7.01 0001689548-23-000059 001-39620 23724952 34 179083 1 1
2023-03-10 SC 13G SC 13G 0001193125-23-067238 005-92098 23722645 34 96725
2023-03-03 8-K 8-K 7.01,8.01,9.01 0001689548-23-000056 001-39620 23701641 34 5638889 1 1
2023-02-14 SC 13G/A SCHEDULE 13G/A, AMENDMENT #2 0000899140-23-000377 005-92098 23629176 34 104531
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021576 005-92098 23628971 34 105984
2023-02-14 SC 13G/A SC 13G/A 0001580642-23-000865 005-92098 23626569 34 58757
2023-02-13 4 FORM 4 0001689548-23-000051 4717
2023-02-13 4 FORM 4 0001689548-23-000049 4700
2023-02-13 4 FORM 4 0001689548-23-000048 4728
2023-02-10 SC 13G/A SC 13G/A 0001193125-23-032613 005-92098 23612134 34 48623
2023-02-09 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-23-011530,2023-02-09 9999999995-23-000344 333-260726 23608384 33 1706
2023-02-09 SC 13G/A JHG PLC OWNS <5% 0001274173-23-000021 005-92098 23605564 34 9996
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-016756 005-92098 23604042 34 12966
2023-02-07 S-8 FORM S-8 0001104659-23-011536 333-269615 23592976 33 103509
2023-02-07 POS AM POS AM 0001104659-23-011530 333-260726 23592961 33 808517
2023-02-07 10-K 10-K 0001689548-23-000044 001-39620 23592845 34 9860752 1 1
2023-02-07 8-K 8-K 2.02,7.01,9.01 0001689548-23-000043 001-39620 23592839 34 6585236 1 1
2023-02-07 POSASR POSASR 0001104659-23-011502 333-260726 23592829 33 636137
2023-02-02 SC 13G d9931115_13g.htm 0000919574-23-000666 005-92098 23580436 34 172572
2023-02-01 SC 13G/A us74006w1080_020123.txt 0001306550-23-006397 005-92098 23577612 34 13106
2023-01-25 SC 13G d9929037_13g.htm 0000919574-23-000469 005-92098 23552464 34 152919
2023-01-17 4 FORM 4 0001689548-23-000028 5443
2023-01-17 4 FORM 4 0001689548-23-000027 5432
2023-01-17 4 FORM 4 0001689548-23-000026 5421
2023-01-17 4 FORM 4 0001689548-23-000025 5416
2023-01-17 4 FORM 4 0001689548-23-000024 5441
2023-01-13 4 FORM 4 0001689548-23-000018 5339
2023-01-13 4 FORM 4 0001689548-23-000017 5320
2023-01-13 4 FORM 4 0001689548-23-000016 5329
2023-01-13 4 FORM 4 0001689548-23-000015 5342
2023-01-13 4 FORM 4 0001689548-23-000014 5315
2023-01-09 4 FORM 4 0001689548-23-000008 4717
2023-01-09 4 FORM 4 0001689548-23-000007 4701
2023-01-09 4 FORM 4 0001689548-23-000006 4728
2023-01-09 4 FORM 4 0001689548-23-000005 4728
2022-11-28 8-K 8-K 7.01,8.01,9.01 0001689548-22-000134 001-39620 221421128 34 6102547 1 1
2022-11-21 4 FORM 4 0001689548-22-000131 4726
2022-11-21 4 FORM 4 0001689548-22-000129 4744
2022-11-21 4 FORM 4 0001689548-22-000127 4719
2022-11-09 10-Q 10-Q 0001689548-22-000125 001-39620 221372557 34 4769008 1 1
2022-11-09 8-K 8-K 2.02,7.01,9.01 0001689548-22-000124 001-39620 221372464 34 6092243 1 1
2022-10-11 SC 13G/A Praxis_Precision.txt 0000093751-22-000608 005-92098 221303570 34 8353
2022-09-07 8-K 8-K 8.01 0001689548-22-000118 001-39620 221229936 34 180107 1 1
2022-08-12 8-K 8-K 5.02,9.01 0001689548-22-000113 001-39620 221160631 34 185916 1 1
2022-08-08 10-Q 10-Q 0001689548-22-000111 001-39620 221144382 34 5220872 1 1
2022-08-08 8-K 8-K 2.02,7.01,8.01,9.01 0001689548-22-000110 001-39620 221144285 34 4673653 1 1
2022-07-26 8-K 8-K 5.02,9.01 0001689548-22-000099 001-39620 221107457 34 227656 1 1
2022-07-11 8-K/A 8-K/A 5.02 0001689548-22-000096 001-39620 221077327 34 177059 1 1
2022-07-11 SC 13G PRAXIS_PRECISION_MED_INC.txt 0000093751-22-000573 005-92098 221076547 34 10243
2022-07-11 SC 13G/A filing.txt 0000315066-22-001660 005-92098 221075944 34 7961
2022-06-24 4 FORM 4 0001689548-22-000094 5439
2022-06-24 4 FORM 4 0001689548-22-000093 5427
2022-06-24 4 FORM 4 0001689548-22-000092 5411
2022-06-24 4 FORM 4 0001689548-22-000091 5412
2022-06-24 4 FORM 4 0001689548-22-000090 5438
2022-06-24 4 FORM 4 0001689548-22-000089 5419
2022-06-21 4 FORM 4 0001689548-22-000082 4492
2022-06-17 SC 13G SC 13G 0001104659-22-072412 005-92098 221024150 34 99781
2022-06-14 4 FORM 4 0001689548-22-000080 4463
2022-06-13 4 FORM 4 0001689548-22-000078 4492
2022-06-09 4 FORM 4 0001689548-22-000076 4993
2022-06-09 4 FORM 4 0001689548-22-000075 4961
2022-06-06 8-K 8-K 8.01 0001689548-22-000072 001-39620 22996717 34 183450 1 1
2022-06-01 8-K 8-K 5.07 0001689548-22-000070 001-39620 22987903 34 198213 1 1
2022-05-27 4 FORM 4 0001689548-22-000068 5291
2022-05-27 4 FORM 4 0001689548-22-000067 5283
2022-05-27 4 FORM 4 0001689548-22-000066 5259
2022-05-27 4 FORM 4 0001689548-22-000065 5293
2022-05-27 4 FORM 4 0001689548-22-000064 5233
2022-05-27 4 FORM 4 0001689548-22-000063 5261
2022-05-24 4 FORM 4 0001689548-22-000056 5283
2022-05-24 3 FORM 3 0001689548-22-000054 7447
2022-05-23 DEFA14A DEFA14A 0001689548-22-000052 001-39620 22949712 34 16837
2022-05-23 8-K 8-K 5.02 0001689548-22-000051 001-39620 22949710 34 178685 1 1
2022-05-18 4 FORM 4 0001689548-22-000048 4719
2022-05-18 4 FORM 4 0001689548-22-000046 4747
2022-05-18 4 FORM 4 0001689548-22-000044 4725
2022-05-18 4 FORM 4 0001689548-22-000042 4746
2022-05-18 4 FORM 4 0001689548-22-000040 4735
2022-05-09 10-Q 10-Q 0001689548-22-000038 001-39620 22904962 34 4179841 1 1
2022-05-09 8-K 8-K 2.02,7.01,8.01,9.01 0001689548-22-000037 001-39620 22904833 34 7053919 1 1
2022-04-29 8-K 8-K 8.01 0001689548-22-000029 001-39620 22870458 34 178677 1 1
2022-04-27 8-K 8-K 7.01,9.01 0001689548-22-000026 001-39620 22860269 34 16912058 1 1
2022-04-14 DEFA14A DEFA14A 0001689548-22-000023 001-39620 22827992 34 1365355
2022-04-14 DEF 14A DEF 14A 0001689548-22-000022 001-39620 22827849 34 2052104
2022-02-28 S-8 FORM S-8 0001104659-22-028100 333-263081 22689840 33 83679
2022-02-28 10-K 10-K 0001689548-22-000014 001-39620 22683800 34 19948606 1 1
2022-02-28 8-K 8-K 2.02,7.01,9.01 0001689548-22-000013 001-39620 22683756 34 6295426 1 1
2022-02-15 4 FORM 4 0001689548-22-000008 4718
2022-02-15 4 FORM 4 0001689548-22-000007 4703
2022-02-15 4 FORM 4 0001689548-22-000006 4701
2022-02-15 4 FORM 4 0001689548-22-000005 4729
2022-02-14 SC 13G/A SCHEDULE 13G (AMENDMENT NO. 1) 0000899140-22-000321 005-92098 22633235 34 98823
2022-02-14 SC 13G/A SC 13G/A 0001580642-22-000832 005-92098 22627717 34 55940
2022-02-11 SC 13G JANUS HENDERSON GROUP PLC OWNS >5% 0001274173-22-000065 005-92098 22621047 34 10509
2022-02-11 SC 13G/A SC 13G/A 0001193125-22-035552 005-92098 22616546 34 206957
2022-02-10 SC 13G SCHEDULE 13G 0001104659-22-018362 005-92098 22610616 34 12932
2022-02-09 SC 13G/A filing.txt 0000315066-22-001319 005-92098 22604788 34 8397
2022-02-04 SC 13G us74006w1080_020422.txt 0000834237-22-007265 005-92098 22593482 34 13274
2022-01-11 4 OWNERSHIP DOCUMENT 0001104659-22-003164 7614
2022-01-11 4 OWNERSHIP DOCUMENT 0001104659-22-003163 7600
2022-01-11 4 OWNERSHIP DOCUMENT 0001104659-22-003162 7600
2022-01-11 4 OWNERSHIP DOCUMENT 0001104659-22-003160 7600
2022-01-11 4 OWNERSHIP DOCUMENT 0001104659-22-003158 7628

Latest XBRL company facts

One latest value per concept from companyfacts (251 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 27.95M 2026-11-04 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
dei EntityPublicFloat Entity Public Float USD 883.20M 2025-06-30 2025 FY 10-K 2026-02-19 0001689548-26-000029
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 16.99M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001689548-26-000039
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 3.02M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001689548-26-000039
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001689548-26-000039
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 55.53M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001689548-26-000039
ecd PeoTotalCompAmt PeoTotalCompAmt USD 8.71M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001689548-26-000039
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 35.71 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001689548-26-000039
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 15.02M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 2.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 36.75M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 0 2022-12-31 2022 FY 10-K 2023-02-07 0001689548-23-000044
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.32M 2021-09-30 2021 Q3 10-Q 2021-11-03 0001689548-21-000094
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.50M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -5.73M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 2.68B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 493,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD 950,000 2020-10-01 2020-12-31 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 14.89M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 229,000 2021-04-01 2021-06-30 2021 Q3 10-Q 2021-11-03 0001689548-21-000094
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 43.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 2.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap Assets Assets USD 1.31B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AssetsCurrent Assets, Current USD 762.80M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 986.34M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2022-12-31 2023 FY 10-K 2024-03-05 0001689548-24-000034
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 173,000 2022-12-31 2023 FY 10-K 2024-03-05 0001689548-24-000034
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 39.05M 2022-12-31 2023 FY 10-K 2024-03-05 0001689548-24-000034
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 540.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 383.47M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 239.64M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001689548-25-000111
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 117.63M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001689548-25-000111
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 924.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 110,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001689548-26-000083
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 361.85M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 62.17M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -165.46M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-11 0001689548-21-000042
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 1.30B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 361.85M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 4.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 6.64M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 27.95M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 27.95M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap CommonStockValue Common Stock, Value, Issued USD 15,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -276.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2024-12-31 2024 FY 10-K 2025-02-28 0001689548-25-000040
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-02-28 0001689548-25-000040
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 25.07M 2020-10-20 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 471,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 471,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-04 0001689548-25-000092
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostCurrent Debt Securities, Available-for-sale, Amortized Cost, Current USD 39.05M 2022-12-31 2023 FY 10-K 2024-03-05 0001689548-24-000034
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent Debt Securities, Available-for-sale, Amortized Cost, Noncurrent USD 31.67M 2021-12-31 2022 FY 10-K 2023-02-07 0001689548-23-000044
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 878.10M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions security 213 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 23,000 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2020-12-31 2020 FY 10-K 2021-03-17 0001689548-21-000016
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 306.63M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 59.25M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 23,000 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 170.16M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 657.20M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 649.50M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 515.60M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 7.70M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 44.21M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 30.58M 2024-12-31 2024 FY 10-K 2025-02-28 0001689548-25-000040
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 9.51M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 4.44M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 306.61M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 1.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap Depreciation Depreciation USD 105,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap DividendsStock Dividends, Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-07 0001689548-23-000044
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -9.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.71 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-11 0001689548-21-000042
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -9.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.245 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.032 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.026 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001689548-25-000040
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD -3.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.042 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent pure 0.002 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-17 0001689548-21-000016
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.039 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 75.20M 2021-09-30 2021 Q3 10-Q 2021-11-03 0001689548-21-000094
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001689548-25-000040
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 98.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap HostingArrangementServiceContractImplementationCostCapitalizedAfterAccumulatedAmortization Hosting Arrangement, Service Contract, Implementation Cost, Capitalized, after Accumulated Amortization USD 3.20M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap HostingArrangementServiceContractImplementationCostExpenseAmortization Hosting Arrangement, Service Contract, Implementation Cost, Expense, Amortization USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -302.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -302.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 42,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 224,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 471,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 224,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 74.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -63.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 7,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 65,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 417,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 12.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -9.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -804,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -5,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-17 0001689548-21-000016
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 6.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap IncreaseInCarryingAmountOfRedeemablePreferredStock Increase in Carrying Amount of Redeemable Preferred Stock USD 493,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-23 0001193125-20-301222
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 773,000 2026-06-30 2026 Q2 10-Q 2026-08-06 0001689548-26-000083
us-gaap InterestIncomeOther Interest Income, Other USD 957,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-07 0001689548-23-000044
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 134,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-23 0001193125-20-301222
us-gaap LeaseCost Lease, Cost USD 1.15M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.09 2021-09-30 2021 Q3 10-Q 2021-11-03 0001689548-21-000094
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 110,000 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 110,000 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 110,000 2021-12-31 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 110,000 2022-12-31 2022 FY 10-K 2023-02-07 0001689548-23-000044
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 110,000 2023-12-31 2023 FY 10-K 2024-03-05 0001689548-24-000034
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 0 2021-09-30 2021 Q3 10-Q 2021-11-03 0001689548-21-000094
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap Liabilities Liabilities USD 52.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.31B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap LiabilitiesCurrent Liabilities, Current USD 52.50M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap MarketableSecurities Marketable Securities USD 568.80M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 383.47M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 540.70M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 614.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -365.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -245.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -270.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -167.06M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 39.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap OperatingExpenses Operating Expenses USD 309.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -309.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.40M 2026-03-01 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 732,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 674,000 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 843,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.09 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 5.18M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 6.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 3,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-07 0001689548-23-000044
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -6.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 7,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 39.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD -2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-06 0001689548-24-000101
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 4.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap PaymentsForRepurchaseOfRedeemableConvertiblePreferredStock Payments for Repurchase of Redeemable Convertible Preferred Stock USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-05 0001689548-24-000034
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 13.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 720.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap PaymentsToDevelopSoftware Payments to Develop Software USD 773,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001689548-26-000083
us-gaap PreferredStockAmountOfPreferredDividendsInArrears Preferred Stock, Amount of Preferred Dividends in Arrears USD 7.80M 2020-09-30 2020 FY 10-K 2021-03-17 0001689548-21-000016
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 17.48M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-07 0001689548-23-000044
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 13.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 2.40B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 361.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 7.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.65M 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.90M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap RedeemablePreferredStockDividends Redeemable Preferred Stock Dividends USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 211.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap RestrictedCash Restricted Cash USD 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 416,000 2024-12-31 2024 FY 10-K 2025-02-28 0001689548-25-000040
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 600,000 2020-09-30 2020 Q3 10-Q 2020-11-23 0001193125-20-301222
us-gaap RestructuringAndRelatedCostIncurredCost Restructuring and Related Cost, Incurred Cost USD 1.00M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-05 0001689548-24-000034
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.41B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap Revenues Revenues USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 7.00M 2021-11-04 2021-12-31 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 391,997 2021-11-04 2021-12-31 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 43.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 8.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.801 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.881 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-23 0001193125-20-301222
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.857 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-23 0001193125-20-301222
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.039 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.009 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-23 0001193125-20-301222
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.004 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-23 0001193125-20-301222
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 0 2021-12-31 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 277.42M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.33M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 102.51 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 27.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 9,929 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 109,647 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 207.72 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 378.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 103.06 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 378.58M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 103.06 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 0.03 2021-11-03 2022 FY 10-K 2023-02-07 0001689548-23-000044
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 66 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 73.51 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 292.6 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.26B 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.067 2023-11-28 2024 Q3 10-Q 2024-11-06 0001689548-24-000101
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 98.41M 2021-04-01 2021-06-30 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 102,607 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 233.18M 2020-10-01 2020-12-31 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 809,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.74M 2024-10-01 2024-12-31 2024 FY 10-K 2025-02-28 0001689548-25-000040
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-09 0001689548-22-000038
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.42M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap SubleaseIncome Sublease Income USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-17 0001689548-21-000016
us-gaap TangibleAssetImpairmentCharges Tangible Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 8.05M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-23 0001193125-20-301222
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap TemporaryEquityAggregateAmountOfRedemptionRequirement Temporary Equity, Aggregate Amount of Redemption Requirement USD 121.12M 2019-12-31 2020 FY 10-K 2021-03-17 0001689548-21-000016
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 121.12M 2019-12-31 2020 FY 10-K 2021-03-17 0001689548-21-000016
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-03 0001689548-21-000094
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 121.12M 2019-12-31 2020 FY 10-K 2021-03-17 0001689548-21-000016
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 53.64M 2020-10-20 2021 FY 10-K 2022-02-28 0001689548-22-000014
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 35.46M 2019-12-31 2020 FY 10-K 2021-03-17 0001689548-21-000016
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 35.46M 2019-12-31 2020 FY 10-K 2021-03-17 0001689548-21-000016
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 0 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap TreasuryStockShares Treasury Stock, Shares shares 0 2022-06-30 2022 Q2 10-Q 2022-08-08 0001689548-22-000111
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -86,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-11 0001689548-21-000042
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 88.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap VariableLeaseCost Variable Lease, Cost USD 51,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001689548-26-000029
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 29.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 38.47M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-11 0001689548-21-000042
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 29.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-09 0001689548-26-000089

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →